Clinical and epidemiological studies determined a reduction in the incidence of ischemic heart disease during ovulation in women, while in aged-matched men, menopause, or oral contraceptive use, the incidence of this syndrome is increased in parallel with the cessation of relaxin-2 luteal secretion, caused by the absence of ovarian activity [127]. This evidence concerns the gene RLN2 and coronary artery disorder.